• Home
  • About Us
  • The Experts
  • Outreach
  • Discoveries
  • Glioblastoma guide
  • Contact Us
  • Database
  • More
    • Home
    • About Us
    • The Experts
    • Outreach
    • Discoveries
    • Glioblastoma guide
    • Contact Us
    • Database
  • Home
  • About Us
  • The Experts
  • Outreach
  • Discoveries
  • Glioblastoma guide
  • Contact Us
  • Database

NeuroMarkers
Consulting and Research

NeuroMarkers Consulting and ResearchNeuroMarkers Consulting and ResearchNeuroMarkers Consulting and Research

Welcome

NeuroMarkers is a Nonprofit Corporation exempt from federal income tax under Internal Revenue Code (IRC) Section 501(c)(3).

The scope of NeuroMarkers is to develop diagnostic, prognostic and therapeutic markers for brain tumors, by cutting edge clinical research and state-of-the-art consultation services.

Find out more

Help Our Cause

Donations to NeuroMarkers are tax-deductible.

Your support and contributions will enable us to meet our goals and improve brain cancer diagnosis and treatment. Your generous donation will fund our mission.

Pay with PayPal or a debit/credit card

Services

State-of-the-art Molecular Neuropathology

The integrated molecular-histologic diagnosis rendered at NeuroMarkers is based on the latest scientific and technological discoveries:

  • Molecular interpretation of next generation sequencing (NGS) data from 650-gene-panel and whole transcriptome 
  • Diagnostic criteria based on the latest World Health Organization (WHO) guidelines
  • Implementation of the most sophisticated molecular classification for glioblastoma developed by the NeuroMarkers Medical Director, Dr. Georgescu
  • Recommendation for genetic testing in pertinent cases

A Healthy Community through Innovation

When you choose NeuroMarkers, you join a community. We work with all the members of our community to build a network of people fostering progress in brain tumor diagnosis, management and research.

  • Better understanding of pediatric brain tumors through development of novel diagnostic markers 
  • Study of mechanisms of tumor reprogramming and drug resistance
  • Breakthroughs in glioblastoma diagnosis, prognosis and therapy design 
  • Development of precision neuromarkers for tumor growth and interaction with the immune microenvironment

Areas of Specialty

General and Molecular Neuropathology

  1. All brain and spine tumors: primary and metastatic, adult and pediatric, sporadic and syndromic.
  2. Cerebrovascular pathology
  3. Infectious brain pathology
  4. Muscle and nerve pathology
  5. Ophthalmic pathology
  6. Genetic counseling


Copyright © 2025 NeuroMarkers Consulting and Research - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept